子宮筋腫治療薬の世界市場は、2022年に約18億米ドルと評価され、予測期間の2023年から2030年には10.2%以上の健全な成長率で成長すると予測されています。子宮筋腫治療薬は、子宮筋腫を治療するために特別に開発されました。これは、生殖年齢の女性の子宮に影響を及ぼす一般的な非癌性疾患です。子宮筋腫治療薬市場は、新製品の発売数の増加や子宮筋腫の有病率の上昇などの要因によって牽引されています。
これらの薬剤には、GnRHアゴニスト、黄体ホルモン放出IUD、SPRM、非ステロイド性抗炎症薬、トラネキサム酸などがあり、子宮筋腫の縮小、大量出血や痛みなどの症状の管理、またはその両方を目的としています。2022年6月、経口GnRH拮抗薬であるYseltyが、子宮筋腫の中等度から重度の症状に対する治療薬としてEMAから承認されました。GnRH拮抗薬であるMyfembreeは、子宮筋腫に伴う大量出血の治療薬として米国FDAから認可されました。それとともに2021年5月、Myovant Sciences社とPfizer社は、子宮筋腫に伴う大量出血の治療薬として特別に適応のあるMyfembree（relugolix）の米国FDA認可を取得しました。これらの新しく発売された薬の有効性が市場の成長を生み出しています。また、子宮筋腫治療に対する女性の意識の高まりや、子宮筋腫の早期発見・早期治療に取り組む様々な政府が、市場に有利な機会を生み出す可能性があります。しかし、子宮筋腫治療薬の高コストが市場の成長を妨げています。
世界の子宮筋腫治療薬市場調査の対象となる主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東およびアフリカが含まれます。2022年には、子宮筋腫の有病率の上昇、筋腫による妊娠合併症の増加、新規治療オプションの承認により、北アメリカが市場を支配しました。アジア太平洋地域は、インドや中国といった人口の多い国の存在により、予測期間中に最も急成長する地域と考えられています。グローバル企業は、同地域での治療法の開発・商業化のために現地企業と契約を結んでいます。
この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。
このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Uterine fibroid treatment drugs Market, by Region, 2020-2030 (USD Billion)
1.2.2. Uterine fibroid treatment drugs Market, by Drug Class, 2020-2030 (USD Billion)
1.2.3. Uterine fibroid treatment drugs Market, by Type, 2020-2030 (USD Billion)
1.2.4. Uterine fibroid treatment drugs Market, by End User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Uterine fibroid treatment drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Uterine fibroid treatment drugs Market Dynamics
3.1. Uterine fibroid treatment drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing number of new product launches
3.1.1.2. Rising prevalence of uterine fibroid
3.1.2. Market Challenges
3.1.2.1. High Cost of Uterine fibroid treatment drugs
3.1.3. Market Opportunities
3.1.3.1. Growing awareness of uterine fibroid in women
3.1.3.2. Government focus on early detection of uterine and treatment
Chapter 4. Global Uterine fibroid treatment drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Uterine fibroid treatment drugs Market, by Drug Class
5.1. Market Snapshot
5.2. Global Uterine fibroid treatment drugs Market by Drug Class, Performance - Potential Analysis
5.3. Global Uterine fibroid treatment drugs Market Estimates & Forecasts by Drug Class 2020-2030 (USD Billion)
5.4. Uterine fibroid treatment drugs Market, Sub Segment Analysis
5.4.1. Gonadotropin-releasing Hormone (GnRH) Agonists
5.4.2. Gonadotropin-releasing Hormone (GnRH) Antagonists
5.4.3. Progestin-releasing Intrauterine Device (IUD) & Contraceptives
5.4.4. Non-hormonal Medications
5.4.5. Others
Chapter 6. Global Uterine fibroid treatment drugs Market, by Type
6.1. Market Snapshot
6.2. Global Uterine fibroid treatment drugs Market by Type, Performance - Potential Analysis
6.3. Global Uterine fibroid treatment drugs Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
6.4. Uterine fibroid treatment drugs Market, Sub Segment Analysis
6.4.1. Subserosal Fibroids
6.4.2. Intramural Fibroids
6.4.3. Submucosal Fibroids
6.4.4. Pedunculated Fibroids
Chapter 7. Global Uterine fibroid treatment drugs Market, by End User
7.1. Market Snapshot
7.2. Global Uterine fibroid treatment drugs Market by End User, Performance - Potential Analysis
7.3. Global Uterine fibroid treatment drugs Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
7.4. Uterine fibroid treatment drugs Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Retail pharmacies
7.4.3. Other
Chapter 8. Global Uterine fibroid treatment drugs Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Uterine fibroid treatment drugs Market, Regional Market Snapshot
8.4. North America Uterine fibroid treatment drugs Market
8.4.1. U.S. Uterine fibroid treatment drugs Market
8.4.1.1. Drug Class breakdown estimates & forecasts, 2020-2030
8.4.1.2. Type breakdown estimates & forecasts, 2020-2030
8.4.1.3. End User breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Uterine fibroid treatment drugs Market
8.5. Europe Uterine fibroid treatment drugs Market Snapshot
8.5.1. U.K. Uterine fibroid treatment drugs Market
8.5.2. Germany Uterine fibroid treatment drugs Market
8.5.3. France Uterine fibroid treatment drugs Market
8.5.4. Spain Uterine fibroid treatment drugs Market
8.5.5. Italy Uterine fibroid treatment drugs Market
8.5.6. Rest of Europe Uterine fibroid treatment drugs Market
8.6. Asia-Pacific Uterine fibroid treatment drugs Market Snapshot
8.6.1. China Uterine fibroid treatment drugs Market
8.6.2. India Uterine fibroid treatment drugs Market
8.6.3. Japan Uterine fibroid treatment drugs Market
8.6.4. Australia Uterine fibroid treatment drugs Market
8.6.5. South Korea Uterine fibroid treatment drugs Market
8.6.6. Rest of Asia Pacific Uterine fibroid treatment drugs Market
8.7. Latin America Uterine fibroid treatment drugs Market Snapshot
8.7.1. Brazil Uterine fibroid treatment drugs Market
8.7.2. Mexico Uterine fibroid treatment drugs Market
8.8. Middle East & Africa Uterine fibroid treatment drugs Market
8.8.1. Saudi Arabia Uterine fibroid treatment drugs Market
8.8.2. South Africa Uterine fibroid treatment drugs Market
8.8.3. Rest of Middle East & Africa Uterine fibroid treatment drugs Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Myovant Sciences Gmbh
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Pfizer Inc.
9.3.3. Abbvie Inc.
9.3.4. Ferring B.v
9.3.5. AstraZeneca
9.3.6. Bayer AG
9.3.7. Amring Pharmaceuticals Inc.
9.3.8. Watson Pharma Inc.
9.3.9. Boston scientific corporation
9.3.10. Gynesonics Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
List of Tables
TABLE 1. Global Uterine fibroid treatment drugs Market, report scope
TABLE 2. Global Uterine fibroid treatment drugs Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Uterine fibroid treatment drugs Market estimates & forecasts by Drug Class 2020-2030 (USD Billion)
TABLE 4. Global Uterine fibroid treatment drugs Market estimates & forecasts by Type 2020-2030 (USD Billion)
TABLE 5. Global Uterine fibroid treatment drugs Market estimates & forecasts by End User 2020-2030 (USD Billion)
TABLE 6. Global Uterine fibroid treatment drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Uterine fibroid treatment drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Uterine fibroid treatment drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Uterine fibroid treatment drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Uterine fibroid treatment drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Uterine fibroid treatment drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Uterine fibroid treatment drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Uterine fibroid treatment drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Uterine fibroid treatment drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Uterine fibroid treatment drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Uterine fibroid treatment drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Uterine fibroid treatment drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Uterine fibroid treatment drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Uterine fibroid treatment drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Uterine fibroid treatment drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Uterine fibroid treatment drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Uterine fibroid treatment drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Uterine fibroid treatment drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Uterine fibroid treatment drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Uterine fibroid treatment drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Uterine fibroid treatment drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Uterine fibroid treatment drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Uterine fibroid treatment drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Uterine fibroid treatment drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Uterine fibroid treatment drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Uterine fibroid treatment drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Uterine fibroid treatment drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Uterine fibroid treatment drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Uterine fibroid treatment drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Uterine fibroid treatment drugs Market
TABLE 71. List of primary sources, used in the study of global Uterine fibroid treatment drugs Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
List of figures
FIG 1. Global Uterine fibroid treatment drugs Market, research methodology
FIG 2. Global Uterine fibroid treatment drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Uterine fibroid treatment drugs Market, key trends 2022
FIG 5. Global Uterine fibroid treatment drugs Market, growth prospects 2023-2030
FIG 6. Global Uterine fibroid treatment drugs Market, porters 5 force model
FIG 7. Global Uterine fibroid treatment drugs Market, pest analysis
FIG 8. Global Uterine fibroid treatment drugs Market, value chain analysis
FIG 9. Global Uterine fibroid treatment drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Uterine fibroid treatment drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Uterine fibroid treatment drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Uterine fibroid treatment drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Uterine fibroid treatment drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Uterine fibroid treatment drugs Market, regional snapshot 2020 & 2030
FIG 15. North America Uterine fibroid treatment drugs Market 2020 & 2030 (USD Billion)
FIG 16. Europe Uterine fibroid treatment drugs Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Uterine fibroid treatment drugs Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Uterine fibroid treatment drugs Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Uterine fibroid treatment drugs Market 2020 & 2030 (USD Billion)
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
